Virtus ETF Advisers LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,126,000
+125.2%
32,688
+9.2%
0.59%
+149.4%
Q2 2020$500,000
+84.5%
29,935
+59.2%
0.24%
+111.6%
Q1 2020$271,000
-60.3%
18,800
-7.8%
0.11%
+0.9%
Q4 2019$682,000
+157.4%
20,386
+61.4%
0.11%
+109.4%
Q3 2019$265,000
-4.7%
12,634
-5.3%
0.05%
-10.2%
Q2 2019$278,000
+3.7%
13,338
+11.2%
0.06%
-89.6%
Q1 2019$268,000
-18.0%
11,993
-12.4%
0.57%
+917.9%
Q4 2018$327,000
-24.7%
13,687
-13.9%
0.06%
+24.4%
Q3 2018$434,000
-40.8%
15,893
-41.7%
0.04%
-93.1%
Q2 2018$733,000
+4.3%
27,252
+23.3%
0.65%
+6.2%
Q1 2018$703,000
+79.8%
22,101
+113.8%
0.61%
+24.2%
Q4 2017$391,000
-11.9%
10,336
-42.3%
0.49%
+718.3%
Q3 2017$444,000
+32.9%
17,898
+10.1%
0.06%
+20.0%
Q2 2017$334,000
+23.2%
16,261
+30.4%
0.05%
+4.2%
Q1 2017$271,000
+17.3%
12,472
+10.6%
0.05%
-30.4%
Q4 2016$231,000
-21.2%
11,276
-42.2%
0.07%
-51.4%
Q3 2016$293,000
+38.9%
19,5010.0%0.14%
-9.6%
Q2 2016$211,000
+14.1%
19,501
+42.7%
0.16%
-38.4%
Q1 2016$185,00013,6660.26%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders